United States Non-alcoholic Steatohepatitis Therapeutic & Diagnostic Market Poised for Growth Through Next-Generation Therapies
  The United States holds a leading position in the Non-alcoholic Steatohepatitis Therapeutic & Diagnostic Market, driven by the high prevalence of obesity, type 2 diabetes, and metabolic syndrome, which are major risk factors for liver disease. The country benefits from a strong healthcare infrastructure, significant investments in liver disease research, and the presence of leading...
0 التعليقات 0 المشاركات 50 مشاهدة 0 معاينة